Conagra Brands, Inc. · CAG · FY2026 Q2 · Calendar Q4 2025

Conagra Maintains Outlook as Frozen and Snacks Recover

The quarter supports a measured recovery case: management sees second-half organic sales growth and frozen-market-share recovery, while productivity, supply-chain investment and Project Catalyst are intended to support margins. The evidence remains balanced by Q3 absorption pressure, inflation, pricing risk and the impairment charge.

Reported Before market openNYSEConsumer Defensive $6.85B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.45 Consensus $0.44
EPS surprise +3.2% Reported versus consensus
Reported revenue $2.98B Consensus $2.98B
Revenue surprise -0.0% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -2.5% Event window
SPY move +0.6% Same window
Abnormal move -3.1% Stock minus SPY
Volume 2.4× Versus trailing sessions
Subsequent drift -0.3% Up to 20 sessions
CAGSPY benchmark

Ask FN2 about CAG FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management highlighted the launch of Project Catalyst, completion of the new baked chicken facility with planned capacity expansion, and an impairment charge tied to a higher discount rate. Compared with the prior quarter, the focus shifted toward second-half organic sales growth, frozen promotions and absorbing the Ardent shortfall while maintaining the outlook.

Guidance delta

Management maintained its outlook, expecting organic net-sales growth in the second half and expressing confidence it can absorb the Ardent shortfall while remaining within its EPS range.

Key takeaways

  • Management expects organic net-sales growth in the second half of FY26.
  • Frozen market share has largely been reclaimed, with stronger promotions planned for the back half of FY26.
  • Margin expansion is expected from productivity, supply-chain improvements, selective pricing and Project Catalyst.
  • Innovation is focused on protein, clean-label and value-oriented products.
  • An impairment charge reflected a higher discount rate after a sustained stock-price decline.

Management priorities

  • Roll out Project Catalyst during calendar 2026.
  • Expand capacity at the baked chicken facility.
  • Continue innovation in protein and clean-label products.
  • Use productivity initiatives, supply-chain improvements and selective pricing to support margins.
  • Prioritize debt reduction in potential portfolio optimization activity.

Follow CAG with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
CAG EPS earnings history estimate and actual scatter chart 9 reported fiscal quarters and 4 future estimate-only quarters. Q3 '24 estimate $0.65 Q3 '24 actual $0.69, beat Q4 '24 estimate $0.57 Q4 '24 actual $0.61, beat Q1 '25 estimate $0.59 Q1 '25 actual $0.53, miss Q4 '25 estimate $0.58 Q4 '25 actual $0.56, miss Q1 '26 estimate $0.33 Q1 '26 actual $0.39, beat Q2 '26 estimate $0.44 Q2 '26 actual $0.45, beat Q3 '26 estimate $0.40 Q3 '26 actual $0.39, miss Q4 '26 estimate $0.46 Q4 '26 actual $0.47, beat Q1 '27 estimate $0.28 Q2 '27 estimate $0.40 Q3 '27 estimate $0.37 Q4 '27 estimate $0.39
Show 1 more >

Analyst Consensus ?

ConsensusHold24 ratings
Bullish625.0%
Neutral1458.3%
Bearish416.7%

Analyst 52W Price Targets

$14.16Current
$12Low
$23.73Average
$43High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 28, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Deutsche Bank Hold HoldMaintainSep 18, 2026
Evercore ISI Group In Line In LineMaintainSep 14, 2026
Barclays Overweight OverweightMaintainJul 17, 2026
UBS Neutral NeutralMaintainJul 16, 2026
RBC Capital Sector Perform Sector PerformMaintainJul 16, 2026
JP Morgan Neutral NeutralMaintainJul 16, 2026
Morgan Stanley Equal Weight Equal WeightMaintainJun 5, 2026
Bernstein Underperform Market PerformDowngradeJun 3, 2026
Wells Fargo Underweight UnderweightMaintainMay 18, 2026
Stifel Hold HoldMaintainApr 21, 2026
BNP Paribas Neutral OutperformDowngradeApr 9, 2026
Goldman Sachs Sell SellMaintainApr 2, 2026
TD Cowen Hold HoldMaintainDec 22, 2025
B of A Securities Underperform UnderperformMaintainDec 22, 2025
Jefferies Hold HoldMaintainDec 12, 2025
Citigroup Neutral NeutralMaintainJun 28, 2024
Credit Suisse Neutral NeutralMaintainMar 31, 2023
SunTrust Robinson Humphrey Hold BuyDowngradeMay 11, 2020
CFRA Strong Buy BuyUpgradeMar 12, 2020
Stifel Nicolaus Buy HoldUpgradeOct 30, 2017
Bank of America Buy NeutralUpgradeFeb 12, 2016
KeyBanc Hold BuyDowngradeJun 18, 2014
S&P Capital IQ Buy Strong BuyDowngradeDec 19, 2013
Edward Jones Buy HoldUpgradeDec 13, 2012
Show less

Named analyst price targets

Upside is calculated against the persisted current price $14.16. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Deutsche BankSteve Powers$13$15.12 -8.2%Sep 18, 2026
Evercore ISIAnalyst unavailable$12.5$14.61 -11.7%Sep 14, 2026
UBSPeter Grom$14$14.44 -1.1%Jul 16, 2026
RBC CapitalAnalyst unavailable$14$14.28 -1.1%Jul 16, 2026
BarclaysAnalyst unavailable$16$14.04 +13.0%Jul 8, 2026
RBC CapitalAnalyst unavailable$16$13.89 +13.0%Jun 25, 2026
Deutsche BankSteve Powers$12$13.16 -15.3%Jun 18, 2026
Morgan StanleyMegan Alexander Clapp$13$12.66 -8.2%Jun 5, 2026
Coker PalmerThomas Palmer$14$12.66 -1.1%Jun 5, 2026
BernsteinAnalyst unavailable$12$12.86 -15.3%Jun 3, 2026
UBSPeter Grom$13$12.92 -8.2%Jun 2, 2026
Morgan StanleyMegan Alexander Clapp$15$14.53 +5.9%Apr 23, 2026
Stifel NicolausAnalyst unavailable$15$14.84 +5.9%Apr 21, 2026
BNP ParibasAnalyst unavailable$16$15.55 +13.0%Apr 9, 2026
Wells FargoChris Carey$15$16.98 +5.9%Mar 12, 2026
UBSAnalyst unavailable$20$19.52 +41.2%Feb 13, 2026
Morgan StanleyMegan Alexander Clapp$18$17.38 +27.1%Jan 16, 2026
Wells FargoAnalyst unavailable$18$17.05 +27.1%Jan 5, 2026
BernsteinAlexia Howard$18$17.48 +27.1%Dec 29, 2025
UBSPeter Grom$18$17.26 +27.1%Dec 23, 2025
Deutsche BankSteve Powers$18$17.3 +27.1%Dec 22, 2025
Morgan StanleyAnalyst unavailable$19$17.36 +34.2%Dec 22, 2025
Evercore ISIDavid Palmer$22$17.36 +55.4%Dec 22, 2025
RBC CapitalAnalyst unavailable$20$17.35 +41.2%Dec 22, 2025
RBC CapitalNik Modi$22$17.74 +55.4%Dec 17, 2025
Wells FargoAnalyst unavailable$19$17.83 +34.2%Dec 12, 2025
JefferiesAnalyst unavailable$18$17.6 +27.1%Dec 11, 2025
Stifel NicolausAnalyst unavailable$19$17.44 +34.2%Dec 11, 2025
Goldman SachsAnalyst unavailable$16$17.52 +13.0%Nov 25, 2025
Wells FargoChris Carey$20$19.3 +41.2%Oct 2, 2025
Morgan StanleyMegan Alexander Clapp$20$19.4 +41.2%Jul 11, 2025
BernsteinAlexia Howard$21$19.4 +48.3%Jul 11, 2025
Morgan StanleyMegan Alexander$22$20.52 +55.4%Jul 7, 2025
Evercore ISIDavid Palmer$26$20.99 +83.6%Jul 7, 2025
JefferiesRob Dickerson$30$32.31 +111.9%Sep 24, 2024
Coker PalmerThomas Palmer$33$32.31 +133.1%Sep 24, 2024
Goldman SachsLeah Jordan$36$29.82 +154.2%Aug 12, 2024
Stifel NicolausMatthew Smith$30$28.38 +111.9%Jul 12, 2024
BarclaysAndrew Lazar$34$31.09 +140.1%Apr 8, 2024
Wells FargoChris Carey$32$30.64 +126.0%Apr 5, 2024
Stifel NicolausMatthew Smith$32$30.64 +126.0%Apr 5, 2024
Coker PalmerThomas Palmer$32$30.64 +126.0%Apr 5, 2024
Morgan StanleyPamela Kaufman$32$30.64 +126.0%Apr 5, 2024
CFRAArun Sundaram$34$30.64 +140.1%Apr 4, 2024
Evercore ISIDavid Palmer$32$29.06 +126.0%Apr 4, 2024
RBC CapitalNik Modi$29$29.58 +104.8%Apr 1, 2024
Stifel NicolausMatthew Smith$43$35.96 +203.7%May 19, 2023
Deutsche BankSteve Powers$35$35.52 +147.2%Mar 20, 2023
RBC CapitalConagra Brands$38$40.58 +168.4%Jan 6, 2023
J.P. MorganAnalyst unavailable$43$41 +203.7%Jan 6, 2023
Morgan StanleyAnalyst unavailable$48$40.5 +239.0%Jan 6, 2023
UBSAnalyst unavailable$45$40.66 +217.8%Jan 6, 2023
Credit SuisseAnalyst unavailable$40$39.97 +182.5%Jan 6, 2023
Evercore ISIAnalyst unavailable$42$38.77 +196.6%Dec 29, 2022
Morgan StanleyPamela Kaufman$45$38.49 +217.8%Dec 20, 2022
Deutsche BankSteve Powers$34$38.25 +140.1%Dec 6, 2022
UBSCody Ross$41$35.81 +189.5%Nov 18, 2022
BNP ParibasAnalyst unavailable$42$33.91 +196.6%Nov 15, 2022
Morgan StanleyPamela Kaufman$34$33.83 +140.1%Jul 15, 2022
Morgan StanleyPamela Kaufman$36$35.11 +154.2%Jan 14, 2022
CitigroupWendy Nicholson$37$32.96 +161.3%Jul 14, 2021
Stifel NicolausChristopher Growe$35$32.96 +147.2%Jul 14, 2021
BarclaysAndrew Lazar$39$32.96 +175.4%Jul 14, 2021
Show less

Track every rating change on CAG the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Conagra Brands, Inc., a prominent manufacturer of packaged food products, conducts its business across North America through its various subsidiary companies. The firm organizes its extensive operations into four distinct segments: Grocery & Snacks, Refrigerated & Frozen, International, and Foodservice. The Grocery & Snacks division primarily distributes non-perishable food items through various retail channels within the United States. In contrast, the Refrigerated & Frozen segment focuses on supplying temperature-sensitive food products to comparable U.S. retail outlets.…

Historical context

All CAG earnings

Consumer Defensive peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the CAG recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-28T20:20:57.835484+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-28T20:20:57.832534+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-28. For educational purposes only; not investment advice.